TrialHaematologica2017

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.

Wendy B C Stevens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.